Biologics need 12-year exclusivity in TPP to secure future

11/10/2013 | IPWatchdog.com

The future of biologics can be protected through 12-year data exclusivity under the Trans-Pacific Partnership, Colorado College's Kristina Lybecker writes. Intellectual property protections need to adapt to ensure that the development of biologics remains economically viable while safeguarding patients, she writes.

View Full Article in:

IPWatchdog.com

Published in Briefs: